Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5351-5360 Newer>

Pharmaceutical Executive January 1, 2009 Ann Brandt	Fair Market Value Daryl Johnson, founder of HealthCare Appraisers, talks about fair market value in both the hospital sector and the life sciences.
Pharmaceutical Executive January 1, 2009 Jim Weiss	The Communications Convergence There are three elements of communications that biotech has always lived with, which are now central to the survival of any biopharma company: transparency, speed, and focus. Here's how to make each one work for your company.
Pharmaceutical Executive January 1, 2009 Bob Brown	Getting Graphic The graphic novel emerges as a versatile, effective medical education and marketing tool.
Pharmaceutical Executive January 1, 2009 Stephen E. Gerard	Pharma Confidential In these tough times, how does pharma see its future? How confident are top executives in the future of the industry and their own company? Does size make a difference? Operations executives from a cross section of large, mid-tier, and specialty companies answer these questions and more.
Pharmaceutical Executive January 1, 2009 Patrick Clinton	Getting Across The pharmaceutical industry is in pursuit of new goals.
Pharmaceutical Executive January 1, 2009 Jill Wechsler	FDA Turnaround Time Will more resources and new leadership fix FDA, or is a major overhaul in order?
The Motley Fool January 9, 2009 Brian Orelli	Alnylam Holds Hands With a New Fella Is big pharma turning up its nose at RNAi drugs?
The Motley Fool January 9, 2009 Brian Orelli	Thanks for Nothing, FDA The Food and Drug Administration says there's still enough evidence that Merck and Schering-Plough's Vytorin works to warrant keeping patients on the drug.
Chemistry World January 2009 Derek Lowe	Column: In the pipeline The author discusses the age-old tradition of passing the buck in drug development.
The Motley Fool January 8, 2009 Brian Orelli	FDA Toys With Lilly, and Investors, Again Eli Lilly will have to wait a little longer.
<Older 5351-5360 Newer> Return to current articles.